Medtech Insight is part of the Informa Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

TherMatrx Purchase Gives American Medical Systems In-Office BPH Presence

This article was originally published in The Gray Sheet

Executive Summary

American Medical Systems expects the physician office market for benign prostate hyperplasia treatment to continue to grow by greater than 30% following its acquisition of in-office microwave BPH firm TherMatrx
Advertisement

Related Content

American Medical Buys Laserscope For GreenLight Obstructive BPH Treatment
American Medical Buys Laserscope For GreenLight Obstructive BPH Treatment
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
BSD Medical Plans To File PMA For Cancer Therapy, Prepares Japanese Strategy
AMS Plans PMA Supplement After TherMatrx Claims Draw FDA Scrutiny
AMS Plans PMA Supplement After TherMatrx Claims Draw FDA Scrutiny
Urologix Shares Grow 53% In April, Driven By Profitability; OTC Index Flat
Urologix Shares Grow 53% In April, Driven By Profitability; OTC Index Flat
Boston Scientific To Market Celsion’s Prolieve BPH Device Immediately
Advertisement
UsernamePublicRestriction

Register

MT020446

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel